Open AccessResilient and Accelerated Scale-Up of Subcutaneously Administered Depot–Medroxyprogesterone Acetate in Nigeria (RASuDiN): A Mid-Line Study in COVID-19 Era
Author(s) -
Kehinde Osinowo,
Fintirimam Sambo-Donga,
Oluwaseun Ojomo,
Segun Emmanuel Ibitoye,
Philip Oluwayemi,
Morounfola Okunfulure,
O. A. Ladipo,
Michael Ekholuenetale
Publication year - 2021
Publication title -
open access journal of contraception
Language(s) - English
Resource type - Journals
ISSN - 1179-1527
DOI - 10.2147/oajc.s326106
Subject(s) - medroxyprogesterone acetate , covid-19 , depot , medroxyprogesterone , medicine , scale (ratio) , pandemic , virology , geography , cartography , hormone , disease , archaeology , outbreak , infectious disease (medical specialty)
Injectable contraceptives are fast becoming the method of choice among women in sub-Saharan Africa (SSA). Specifically, the subcutaneously administered depot-medroxyprogesterone acetate (DMPA-SC) is gaining traction as a convenient, private and effective method to address unmet need for family planning (FP). The objective of this study was to determine the trend in DMPA-SC use in Nigeria.